# nCino, Inc.: financial statements, quarterly

NCNO · Nasdaq · CIK 1902733 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/ncno.md) · [Financials](/companies/ncno/financials.md) · [Filings](/companies/ncno/filings.md) · [Insiders](/companies/ncno/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ncno/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [122](/filings/0001902733-24-000188.md) | [124 d](/filings/0001902733-26-000022.md) | [128](/filings/0001902733-25-000076.md) | [132](/filings/0001902733-25-000106.md) | [139](/filings/0001902733-25-000131.md) | [141 d](/filings/0001902733-26-000022.md) | [144](/filings/0001902733-26-000066.md) | [149](/filings/0001902733-26-000101.md) | [152](/filings/0001902733-25-000131.md) | [150 d](/filings/0001902733-26-000022.md) | [159](/filings/0001902733-26-000066.md) | [161](/filings/0001902733-26-000101.md) |
| Cost of revenue | $m | [48.0](/filings/0001902733-24-000188.md) | [49.2 d](/filings/0001902733-26-000022.md) | [51.2](/filings/0001902733-25-000076.md) | [53.9](/filings/0001902733-25-000106.md) | [53.7](/filings/0001902733-25-000131.md) | [57.0 d](/filings/0001902733-26-000022.md) | [57.7](/filings/0001902733-26-000066.md) | [60.7](/filings/0001902733-26-000101.md) | [58.5](/filings/0001902733-25-000131.md) | [57.8 d](/filings/0001902733-26-000022.md) | [58.5](/filings/0001902733-26-000066.md) | [60.2](/filings/0001902733-26-000101.md) |
| Gross profit | $m | [73.9](/filings/0001902733-24-000188.md) | [74.5 d](/filings/0001902733-26-000022.md) | [76.9](/filings/0001902733-25-000076.md) | [78.5](/filings/0001902733-25-000106.md) | [85.1](/filings/0001902733-25-000131.md) | [84.4 d](/filings/0001902733-26-000022.md) | [86.4](/filings/0001902733-26-000066.md) | [88.1](/filings/0001902733-26-000101.md) | [93.7](/filings/0001902733-25-000131.md) | [91.9 d](/filings/0001902733-26-000022.md) | [101](/filings/0001902733-26-000066.md) | [101](/filings/0001902733-26-000101.md) |
| Research and development | $m | [29.0](/filings/0001902733-24-000188.md) | [30.2 d](/filings/0001902733-26-000022.md) | [30.0](/filings/0001902733-25-000076.md) | [34.3](/filings/0001902733-25-000106.md) | [33.0](/filings/0001902733-25-000131.md) | [32.1 d](/filings/0001902733-26-000022.md) | [33.3](/filings/0001902733-26-000066.md) | [34.7](/filings/0001902733-26-000101.md) | [29.5](/filings/0001902733-25-000131.md) | [30.0 d](/filings/0001902733-26-000022.md) | [28.9](/filings/0001902733-26-000066.md) | [31.0](/filings/0001902733-26-000101.md) |
| Operating income | $m | [(12.9)](/filings/0001902733-24-000188.md) | [(3.2) d](/filings/0001902733-26-000022.md) | [(3.7)](/filings/0001902733-25-000076.md) | [(7.9)](/filings/0001902733-25-000106.md) | [(0.8)](/filings/0001902733-25-000131.md) | [(5.7) d](/filings/0001902733-26-000022.md) | [(1.5)](/filings/0001902733-26-000066.md) | [(9.3)](/filings/0001902733-26-000101.md) | [11.7](/filings/0001902733-25-000131.md) | [2.8 d](/filings/0001902733-26-000022.md) | [21.1](/filings/0001902733-26-000066.md) | [13.6](/filings/0001902733-26-000101.md) |
| Interest expense | $m | [0.9](/filings/0001902733-23-000078.md) | [0.9 d](/filings/0001902733-24-000053.md) | [1.5](/filings/0001902733-24-000115.md) | [1.8](/filings/0001902733-25-000106.md) | [1.7](/filings/0001902733-25-000131.md) | [3.8 d](/filings/0001902733-26-000022.md) | [4.5](/filings/0001902733-26-000066.md) | [4.4](/filings/0001902733-26-000101.md) | [4.3](/filings/0001902733-25-000131.md) | [4.2 d](/filings/0001902733-26-000022.md) | [4.5](/filings/0001902733-26-000066.md) | [5.2](/filings/0001902733-26-000101.md) |
| Income tax | $m | [1.8](/filings/0001902733-24-000188.md) | [(3.1) d](/filings/0001902733-26-000022.md) | [(3.0)](/filings/0001902733-25-000076.md) | [1.8](/filings/0001902733-25-000106.md) | [2.6](/filings/0001902733-25-000131.md) | [(3.9) d](/filings/0001902733-26-000022.md) | [4.5](/filings/0001902733-26-000066.md) | [1.2](/filings/0001902733-26-000101.md) | [(0.7)](/filings/0001902733-25-000131.md) | [(8.0) d](/filings/0001902733-26-000022.md) | [1.7](/filings/0001902733-26-000066.md) | [1.5](/filings/0001902733-26-000101.md) |
| Net income | $m | [(16.4)](/filings/0001902733-24-000188.md) | [1.2 d](/filings/0001902733-26-000022.md) | [(3.0)](/filings/0001902733-25-000076.md) | [(11.0)](/filings/0001902733-25-000106.md) | [(5.3)](/filings/0001902733-25-000131.md) | [(18.6) d](/filings/0001902733-26-000022.md) | [5.6](/filings/0001902733-26-000066.md) | [(15.3)](/filings/0001902733-26-000101.md) | [6.5](/filings/0001902733-25-000131.md) | [8.3 d](/filings/0001902733-26-000022.md) | [13.6](/filings/0001902733-26-000066.md) | [5.1](/filings/0001902733-26-000101.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001902733-24-000188.md) | not reported | [(0.03)](/filings/0001902733-25-000076.md) | [(0.10)](/filings/0001902733-25-000106.md) | [(0.05)](/filings/0001902733-25-000131.md) | not reported | [0.05](/filings/0001902733-26-000066.md) | [(0.13)](/filings/0001902733-26-000101.md) | [0.06](/filings/0001902733-25-000131.md) | not reported | [0.12](/filings/0001902733-26-000066.md) | [0.05](/filings/0001902733-26-000101.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0001902733-24-000188.md) | not reported | [(0.03)](/filings/0001902733-25-000076.md) | [(0.10)](/filings/0001902733-25-000106.md) | [(0.05)](/filings/0001902733-25-000131.md) | not reported | [0.05](/filings/0001902733-26-000066.md) | [(0.13)](/filings/0001902733-26-000101.md) | [0.06](/filings/0001902733-25-000131.md) | not reported | [0.13](/filings/0001902733-26-000066.md) | [0.05](/filings/0001902733-26-000101.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [100](/filings/0001902733-24-000188.md) | [112](/filings/0001902733-26-000022.md) | [129](/filings/0001902733-25-000076.md) | [121](/filings/0001902733-25-000106.md) | [258](/filings/0001902733-25-000131.md) | [121](/filings/0001902733-26-000022.md) | [133](/filings/0001902733-26-000066.md) | [123](/filings/0001902733-26-000101.md) | [87.6](/filings/0001902733-25-000131.md) | [88.4](/filings/0001902733-26-000101.md) | [103](/filings/0001902733-26-000066.md) | [83.3](/filings/0001902733-26-000101.md) |
| Current assets | $m | [191](/filings/0001902733-23-000078.md) | [251](/filings/0001902733-25-000026.md) | [237](/filings/0001902733-24-000115.md) | [229](/filings/0001902733-24-000152.md) | [349](/filings/0001902733-24-000188.md) | [302](/filings/0001902733-26-000022.md) | [274](/filings/0001902733-25-000076.md) | [255](/filings/0001902733-25-000106.md) | [209](/filings/0001902733-25-000131.md) | [294](/filings/0001902733-26-000101.md) | [267](/filings/0001902733-26-000066.md) | [243](/filings/0001902733-26-000101.md) |
| Total assets | $m | [1,268](/filings/0001902733-23-000078.md) | [1,340](/filings/0001902733-25-000026.md) | [1,424](/filings/0001902733-24-000115.md) | [1,409](/filings/0001902733-24-000152.md) | [1,517](/filings/0001902733-24-000188.md) | [1,610](/filings/0001902733-26-000022.md) | [1,651](/filings/0001902733-25-000076.md) | [1,616](/filings/0001902733-25-000106.md) | [1,561](/filings/0001902733-25-000131.md) | [1,648](/filings/0001902733-26-000101.md) | [1,608](/filings/0001902733-26-000066.md) | [1,572](/filings/0001902733-26-000101.md) |
| Current liabilities | $m | [173](/filings/0001902733-23-000078.md) | [215](/filings/0001902733-25-000026.md) | [222](/filings/0001902733-24-000115.md) | [211](/filings/0001902733-24-000152.md) | [179](/filings/0001902733-24-000188.md) | [252](/filings/0001902733-26-000022.md) | [261](/filings/0001902733-25-000076.md) | [249](/filings/0001902733-25-000106.md) | [208](/filings/0001902733-25-000131.md) | [294](/filings/0001902733-26-000101.md) | [300](/filings/0001902733-26-000066.md) | [287](/filings/0001902733-26-000101.md) |
| Total liabilities | $m | [236](/filings/0001902733-23-000078.md) | [288](/filings/0001902733-25-000026.md) | [356](/filings/0001902733-24-000115.md) | [330](/filings/0001902733-24-000152.md) | [423](/filings/0001902733-24-000188.md) | [513](/filings/0001902733-26-000022.md) | [570](/filings/0001902733-25-000076.md) | [549](/filings/0001902733-25-000106.md) | [507](/filings/0001902733-25-000131.md) | [579](/filings/0001902733-26-000101.md) | [623](/filings/0001902733-26-000066.md) | [627](/filings/0001902733-26-000101.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [214](/filings/0001902733-26-000101.md) | [253](/filings/0001902733-26-000066.md) | [266](/filings/0001902733-26-000101.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001902733-26-000101.md) | [9.8](/filings/0001902733-26-000066.md) | [9.8](/filings/0001902733-26-000101.md) |
| Shareholders' equity | $m | [1,029](/filings/0001902733-24-000188.md) | [1,049](/filings/0001902733-26-000022.md) | [1,064](/filings/0001902733-25-000106.md) | [1,075](/filings/0001902733-25-000131.md) | [1,088](/filings/0001902733-25-000131.md) | [1,089](/filings/0001902733-26-000101.md) | [1,072](/filings/0001902733-26-000101.md) | [1,057](/filings/0001902733-26-000101.md) | [1,041](/filings/0001902733-25-000131.md) | [1,056](/filings/0001902733-26-000101.md) | [970](/filings/0001902733-26-000101.md) | [930](/filings/0001902733-26-000101.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5.9 d](/filings/0001902733-24-000188.md) | [8.1 d](/filings/0001902733-26-000022.md) | [54.4](/filings/0001902733-25-000076.md) | [5.0 d](/filings/0001902733-25-000106.md) | [5.8 d](/filings/0001902733-25-000131.md) | [(10.0) d](/filings/0001902733-26-000022.md) | [54.3](/filings/0001902733-26-000066.md) | [17.7 d](/filings/0001902733-26-000101.md) | [5.1 d](/filings/0001902733-25-000131.md) | [12.9 d](/filings/0001902733-26-000022.md) | [81.4](/filings/0001902733-26-000066.md) | [34.2 d](/filings/0001902733-26-000101.md) |
| Capital expenditure | $m | [0.6 d](/filings/0001902733-24-000188.md) | [0.4 d](/filings/0001902733-26-000022.md) | [0.3](/filings/0001902733-25-000076.md) | [0.4 d](/filings/0001902733-25-000106.md) | [0.7 d](/filings/0001902733-25-000131.md) | [0.4 d](/filings/0001902733-26-000022.md) | [1.7](/filings/0001902733-26-000066.md) | [5.1 d](/filings/0001902733-26-000101.md) | [0.2 d](/filings/0001902733-25-000131.md) | [0.5 d](/filings/0001902733-26-000022.md) | [0.6](/filings/0001902733-26-000066.md) | [0.2 d](/filings/0001902733-26-000101.md) |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0001902733-25-000076.md) | [0.0 d](/filings/0001902733-25-000106.md) | [0.0 d](/filings/0001902733-25-000131.md) | [0.0 d](/filings/0001902733-26-000022.md) | [40.6](/filings/0001902733-26-000066.md) | [20.0 d](/filings/0001902733-26-000101.md) | [39.5 d](/filings/0001902733-25-000131.md) | [25.0 d](/filings/0001902733-26-000022.md) | [110](/filings/0001902733-26-000066.md) | [65.6 d](/filings/0001902733-26-000101.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [111](/filings/0001902733-23-000078.md) | [112](/filings/0001902733-24-000115.md) | [112](/filings/0001902733-24-000152.md) | [113](/filings/0001902733-24-000188.md) | [114](/filings/0001902733-25-000076.md) | [115](/filings/0001902733-25-000106.md) | [116](/filings/0001902733-25-000131.md) | [117](/filings/0001902733-26-000066.md) | [115](/filings/0001902733-26-000101.md) | [116](/filings/0001902733-25-000131.md) | [109](/filings/0001902733-26-000066.md) | [105](/filings/0001902733-26-000101.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 105,736,174 at 2026-08-20, from the cover of the [10-Q filed 2026-08-25](/filings/0001902733-26-000101.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.